ASP Isotopes (ASPI) EBITDA (2022 - 2026)

ASP Isotopes' EBITDA history runs 5 years deep, the most recent figure standing at -$12.4 million for Q1 2026.

• In Q1 2026, EBITDA fell 70.55% year-over-year to -$12.4 million; the TTM figure through Mar 2026 stood at -$160.3 million (down 379.47% YoY), while the FY2025 annual figure was -$155.1 million, down 360.81% from the prior year.
• EBITDA was -$12.4 million for Q1 2026 at ASP Isotopes, up from -$61.6 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$472642.0 in Q2 2022 to a low of -$74.1 million in Q2 2025.
• Historically, EBITDA has averaged -$13.1 million across 5 years, with a median of -$6.0 million in 2024.
• The sharpest annual moves came in 2023 and 2025: EBITDA slumped 906.9% in 2023, then rose 2.91% in 2025.
• A 5-year view of EBITDA shows it stood at -$1.3 million in 2022, then tumbled by 185.22% to -$3.8 million in 2023, then plunged by 212.63% to -$12.0 million in 2024, then sank by 414.37% to -$61.6 million in 2025, then surged by 79.83% to -$12.4 million in 2026.
• The last three EBITDA figures came in at -$12.4 million (Q1 2026), -$61.6 million (Q4 2025), and -$12.1 million (Q3 2025), per Business Quant data.